|
|
|
|
Kewaunee Scientific Corporation (NASDAQ: KEQU) |
|
|
|
| |
Kewaunee Scientific's Total Debt to Equity
KEQU's quarterly Total Debt to Equity and Total Debt, Equity growth
Due to net new borrowings of %, Total Debt to Equity fell to 0.43, a new company high.
Within Laboratory Analytical Instruments industry in the third quarter 2024, 4 other companies have achieved lower Total Debt to Equity than Kewaunee Scientific in the Q3 2024. While Total Debt to Equity total ranking has deteriorated compared to the second quarter 2024 from 0 to 889 .
Explain Debt to Equity Ratio?
How much Total Debts KEQU´s has?
What are KEQU´s Equity?
|
Select the Comparisons :
|
|
Select the Ratio:
|
|
| KEQU Total Debt to Equity |
(Jan 31 2025)
Q3 |
(Oct 31 2024)
Q2 |
(Jul 31 2024)
Q1 |
(Apr 30 2024)
Q4 |
(Jan 31 2024)
Q3 |
| Y / Y Equity Change |
37.01 % |
39.72 % |
41.87 % |
46.05 % |
24.78 % |
| Y / Y Total Debt Change |
- |
- |
- |
-13.6 % |
- |
| Total Debt to Equity MRQ |
0.43 |
- |
- |
0.06 |
- |
| KEQU's Total
Ranking |
# 889 |
# 0 |
# 0 |
# 223 |
# 0 |
| Seq. Equity Change |
2.41 % |
5.47 % |
2.32 % |
23.97 % |
4.44 % |
| Seq. Total Debt Change |
- |
- |
- |
- |
- |
| Total Debt to Equity third quarter 2024 Company Ranking |
| Within: |
No. |
| Laboratory Analytical Instruments Industry |
# 5 |
| Healthcare Sector |
# 98 |
| Overall Market |
# 889 |
| Total Debt to Equity Statistics |
| High |
Average |
Low |
| 0.43 |
0.13 |
0.02 |
| (Jan 31 2025) |
|
(Jul 31 2019) |
Cumulative Kewaunee Scientific's Total Debt to Equity
KEQU's Total Debt to Equity for the trailling 12 Months
KEQU Total Debt to Equity |
(Jan 31 2025)
12 Months |
(Oct 31 2024)
12 Months |
(Jul 31 2024)
12 Months |
(Apr 30 2024)
12 Months |
(Jan 31 2024)
12 Months |
| Y / Y Equity TTM Growth |
40.96 % |
38.38 % |
34.65 % |
27.92 % |
17.57 % |
| Y / Y Total Debt TTM Growth |
724.14 % |
-13.6 % |
-13.6 % |
-13.6 % |
125.88 % |
| Total Debt to Equity TTM |
0.12 |
0.01 |
0.02 |
0.02 |
0.02 |
| Total Ranking TTM |
# 17
| # 8
| # 4
| # 4
| # 13
|
| Seq. Equity TTM Growth |
7.64 % |
8.52 % |
9.15 % |
10.56 % |
5.67 % |
| Seq. Total Debt TTM Growth |
853.92 % |
0 % |
0 % |
-13.6 % |
0 % |
On the trailing twelve months basis Due to the net new borrowings of % during the trailing twelve months finishing in the Q3 2024, cumulativeTotal Debt to Equity improved to 0.12, a new company high. Total Debt to Equity is the average cumulative value over the last four quarters.
Among companies in the Laboratory Analytical Instruments industry KEQU recorded the lowest Total Debt to Equity. While Total Debt to Equity total ranking has deteriorated during the twelve months ending in the Q3 2024, compared to the prior period, from 8 to 17.
Explain Debt to Equity Ratio?
How much Total Debts KEQU´s has?
What are KEQU´s Equity?
| TTM Total Debt to Equity Company Ranking |
| Within: |
No. |
| Within the Laboratory Analytical Instruments Industry |
# 0 |
| Healthcare Sector |
# 5 |
| Within the Market |
# 17 |
| trailing twelve months Total Debt to Equity Statistics |
| High |
Average |
Low |
| 0.12 |
0.02 |
0.01 | | (Jan 31 2025) |
|
(Apr 30 2020) |
| Companies with similar Total Debt to Equity in the quarter ending Jan 31 2025, within Laboratory Analytical Instruments Industry | Total Debt to Equity | Jan 31 2025 MRQ Total Debt | Jan 31 2025 MRQ Equity | | Bruker Corporation | 1.17 | $ 2,094.300 Millions | $ 1,797.100 Millions | | Waters Corporation | 0.89 | $ 1,626.488 Millions | $ 1,828.507 Millions | | Illumina Inc | 0.84 | $ 1,989.000 Millions | $ 2,373.000 Millions | | Avantor Inc | 0.68 | $ 4,055.800 Millions | $ 5,956.700 Millions | | Harvard Bioscience Inc | 0.58 | $ 36.956 Millions | $ 63.340 Millions | | Agilent Technologies inc | 0.56 | $ 3,363.000 Millions | $ 6,027.000 Millions | | Kewaunee Scientific Corporation | 0.43 | $ 26.463 Millions | $ 62.121 Millions | | Revvity Inc | 0.41 | $ 3,150.718 Millions | $ 7,666.874 Millions | | Bio rad Laboratories Inc | 0.18 | $ 1,201.600 Millions | $ 6,569.300 Millions |
|
Date modified: 2025-03-16T18:30:23+00:00
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
